Researchers at the Nebraska Public Health Laboratory worked round the clock to develop a test for the Andes virus at the center of the deadly cruise ship outbreak ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

The Democratic Republic of Congo has improved its capacity for PCR testing. But it may not be enough to keep up with a rapidly expanding outbreak, and there are no approved rapid tests yet.

According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers ...